Company intelligence / Profile preview

Zuoz

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Zuoz Bio is a precision medicine biotechnology company focused on discovering and developing transformative therapies for patients with kidney diseases. Founded by the former leadership of Goldfinch Bio, the company leverages deep expertise in podocyte biology and kidney genetics to target the underlying molecular drivers of renal disease progression. Zuoz Bio's approach involves identifying specific patient populations that are most likely to respond to targeted small molecule interventions. The company is currently advancing a pipeline of programs aimed at treating chronic kidney disease and rare genetic renal disorders. Headquartered in Cambridge, Massachusetts, Zuoz Bio represents a continuation of efforts to bring precision medicine to the nephrology space.

Therapeutic areas: Nephrology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zuoz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zuoz.

Explore the full profile